AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Quoin Pharmaceuticals, Ltd. Director's Dealing 2023

Mar 8, 2023

35443_dirs_2023-03-07_44493276-be7e-4a8b-8a4e-d148284d30ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Quoin Pharmaceuticals, Ltd. (QNRX)
CIK: 0001671502
Period of Report: 2023-01-01

Reporting Person: Leong Natalie Ee Mun (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Share Option (right to buy)	$0.0035	2032-04-12	Ordinary Shares (64285600)		Direct

Footnotes

F1: The reporting person's original Form 3 incorrectly indicated the options vest in four equal annual installments beginning on April 12, 2023; however, the options vest in three equal annual installments beginning on April 12, 2023.